How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
D Kwaśniewska, M Fudalej, P Nurzyński… - Cancers, 2023 - mdpi.com
Simple Summary Recently observed improvement in the treatment of pancreatic ductal
adenocarcinoma (PDAC) has resulted mainly from improved perioperative care and more …
adenocarcinoma (PDAC) has resulted mainly from improved perioperative care and more …
Anatomical and Biological Considerations to Determine Resectability in Pancreatic Cancer
Simple Summary Surgical candidacy in the treatment of pancreatic cancer is complex. There
are multiple factors influencing if a patient is a good candidate for surgery with or without …
are multiple factors influencing if a patient is a good candidate for surgery with or without …
Is there a role for neoadjuvant systemic therapy for cT4bM0 colon cancer? A propensity score–matched analysis of the National Cancer Database
MK Kamel, A Shchatsko, CA Keane… - Diseases of the Colon …, 2023 - journals.lww.com
BACKGROUND: Nonmetastatic T4b colon cancer has been traditionally treated with upfront
surgery, often requiring technically challenging multiorgan resection. Neoadjuvant …
surgery, often requiring technically challenging multiorgan resection. Neoadjuvant …
Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery
B Li, X Yin, X Ding, G Zhang, H Jiang, C Chen, S Guo… - BMC surgery, 2023 - Springer
Objective To investigate the prognostic prediction of a new indicator, combined by tumor
grade and Ki-67, in patients with resected pancreatic ductal adenocarcinoma (PDAC) …
grade and Ki-67, in patients with resected pancreatic ductal adenocarcinoma (PDAC) …
[PDF][PDF] Borderline resectable pancreatic cancer: challenges for clinical management
A Fawaz, O Abdel-Rahman - Cancer Management and Research, 2022 - Taylor & Francis
Background Pancreatic ductal adenocarcinoma (PDAC) remains a significant worldwide
health problem with a poor prognosis. A borderline resectable pancreatic ductal …
health problem with a poor prognosis. A borderline resectable pancreatic ductal …
[HTML][HTML] Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer
Correspondence to: Jashodeep Datta, MD. Department of Surgery, University of Miami Miller
School of Medicine, 1120 NW 14th Street, Suite 410, Miami, FL 33136, USA; Sylvester …
School of Medicine, 1120 NW 14th Street, Suite 410, Miami, FL 33136, USA; Sylvester …
Evaluating the Benefits of Adjuvant Chemotherapy in Patients with Pancreatic Cancer Undergoing Radical Pancreatectomy after Neoadjuvant Therapy-A Systematic …
J Wu, Y Zhang, H Wang, W Guo, C Li, Y Yu… - Available at SSRN … - papers.ssrn.com
Background: More and more patients with pancreatic cancer (PC) received neoadjuvant
therapy (NAT) and then underwent radical pancreatectomy. However, the benefit of adjuvant …
therapy (NAT) and then underwent radical pancreatectomy. However, the benefit of adjuvant …